Iovance Biotherapeutics, Inc.

IOVA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$8.48-11.30%

2026-10-30

Financials

Valuation Metrics

Iovance Biotherapeutics, Inc.'s Market Cap is $3.79B. At end of 2025 it was $1.11B. Ranked #1160 of 3,114 in US market (top 37%), #377 of 1,469 on NASDAQ (top 26%), #62 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 23%) by Market Cap.

Investment Metrics(as of 2026-10-30)

Metric	Value	Rank
Size
Market Cap	$3.79B	US#1,160/3,114 Sec#62/265
Revenue	$325M	US#2,397/3,114 Sec#91/265
Net Income	$-290M	US—/3,114 Sec—/265
Total Assets	$916M	US#2,512/3,114 Sec#107/265
Net Assets	$736M	US#1,967/3,114 Sec#81/265
Value
P/B	5.14x	US#2,566/3,114 Sec#189/265
P/S	11.65x	US#2,853/3,114 Sec#145/265
FCF Yield	-7.83%	US—/3,114 Sec—/265
Profitability
ROE	-39.33%	US#2,623/3,114 Sec#137/265
ROA	-31.62%	US#2,892/3,114 Sec#162/265
Op. Margin	-92.72%	US#2,710/3,114 Sec#123/265
Revenue Growth	34.55%	US#352/3,114 Sec#57/265
Financial Health
Debt Ratio	24.39%	US#271/3,114 Sec#92/265
Total Debt	$46M	US#2,629/3,114 Sec#156/265
FCF	$-296M	US#2,853/3,114 Sec#233/265
Cash	$111M	US#2,166/3,114 Sec#166/265
Current Ratio	4.34x	US#538/3,114 Sec#160/265
Performance
1Y Return	334.87%	US#5/3,114 Sec#2/265
1M Return	-42.78%	US#32/3,114 Sec#5/265
From 52W High	-44.83%	US#646/3,114 Sec#34/265
1Y MDD	-42.93%	US#1,872/3,114 Sec#114/265
Trading
Volume	29,648,948 shares	US#186/3,114 Sec#12/265
Trading Value	$256M	US#749/3,114 Sec#37/265
Per Share
EPS	$-0.65	US—/3,114 Sec—/265
BPS	$1.65	US#2,603/3,114 Sec#184/265